# Amphenol Corp: Form 10-Q for the period ended Sep 30, 2019

- Company: [Amphenol Corp](/companies/aph.md) (CIK 820313)
- Form: 10-Q
- Filed: 2019-10-25
- Accepted by EDGAR: Oct 25, 2019, 16:40 ET
- Period: 2019-09-30
- Accession: 0001558370-19-009160
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/820313/000155837019009160/aph-20190930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/820313/000155837019009160/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-07-01 to 2019-09-30 | $2.10bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $6.07bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-07-01 to 2019-09-30 | $1.44bn | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2019-01-01 to 2019-09-30 | $4.14bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2019-07-01 to 2019-09-30 | $661.9m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-01-01 to 2019-09-30 | $1.94bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2019-07-01 to 2019-09-30 | $248.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2019-01-01 to 2019-09-30 | $722.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | $413.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | $1.19bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-07-01 to 2019-09-30 | $29.7m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-01-01 to 2019-09-30 | $89.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-07-01 to 2019-09-30 | $91.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-30 | $250.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-07-01 to 2019-09-30 | $280.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-01-01 to 2019-09-30 | $836.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | $0.92 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | $2.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-07-01 to 2019-09-30 | $0.95 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-01-01 to 2019-09-30 | $2.81 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-07-01 to 2019-09-30 | 306,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-01-01 to 2019-09-30 | 307,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-30 | $1.08bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-30 | $223.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2019-07-01 to 2019-09-30 | $68.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months, 2019-01-01 to 2019-09-30 | $205.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2019-01-01 to 2019-09-30 | $558.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-09-30 | $969.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $4.23bn | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $10.68bn | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $2.12bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2019-09-30 | $4.16bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,981 characters.

### Repurchase of Equity Securities

On April 24, 2018, the Company’s Board of Directors authorized a stock repurchase program under which the Company may purchase up to $2.0 billion of the Company’s Common Stock during the three-year period ending April 24, 2021 (the “2018 Stock Repurchase Program”) in accordance with the requirements of Rule 10b-18 of the Securities Exchange Act of 1934, as amended. During the three months ended September 30, 2019, the Company repurchased 1.7 million shares of its Common Stock for $150.0 million under the 2018 Stock Repurchase Program. These treasury shares were retired by the Company. The Company has not repurchased any additional shares of its Common Stock from October 1, 2019 to October 22, 2019, and has remaining authorization to purchase up to $888.1 million of its Common Stock under the 2018 Stock Repurchase Program. The price and timing of any future purchases under the 2018 Stock Repurchase Program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price.

The table below reflects the Company’s stock repurchases for the three months ended September 30, 2019:

*(dollars in millions, except price per share)*

| ​ ​ ​ ​ ​ ​ ​ ​ ​ Period | ​ ​ ​ Total Number of Shares Purchased | ​ ​ ​ ​ ​ | ​ ​ ​ ​ ​ ​ Average Price Paid per Share | ​ ​ ​ ​ Total Number of ​ ​ Shares Purchased as ​ ​ Part of Publicly ​ ​ Announced Plans or ​ Programs | ​ ​ Maximum Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs | ​ |
| --- | ---: | --- | ---: | ---: | ---: | --- |
| July 1 to July 31, 2019 | 105,000 |  | $95.17 | 105,000 | $1,028.1 | ​ |
| August 1 to August 31, 2019 | 1,590,800 | ​ | 87.98 | 1,590,800 | 888.1 | ​ |
| September 1 to September 30, 2019 | — | ​ | — | — | 888.1 | ​ |
| Total | 1,695,800 |  | $88.43 | 1,695,800 | $888.1 | ​ |

## Market risk

As filed, 1,950 characters.

The Company, in the normal course of doing business, is exposed to a variety of risks, including market risks associated with foreign currency exchange rates and changes in interest rates. The Company does not have any significant concentration with any one counterparty. There has been no material change in the Company’s assessment of its sensitivity to foreign currency exchange rate risk since its presentation set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in its 2018 Annual Report. The Company may borrow under its Revolving Credit Facility and Commercial Paper Programs. Any borrowings under the Euro Commercial Paper Program and the 2028 Euro Notes, as discussed in Note 13 of the accompanying Condensed Consolidated Financial Statements, are and may continue to be denominated in foreign currencies, and there can be no assurance that the Company can successfully manage these changes in exchange rates, including in the event of a significant and sudden decline in the value of any of the foreign currencies for which such borrowings are made. In addition, any borrowings under the Revolving Credit Facility either bear interest at or trade at rates that fluctuate with a spread over LIBOR, while any borrowings under the Commercial Paper Programs are subject to floating interest rates. Therefore, when the Company borrows under these debt instruments, the Company is exposed to market risk from exposure to changes in interest rates. As of September 30, 2019, there were no outstanding borrowings under the Revolving Credit Facility, while borrowings under the U.S. Commercial Paper Program and Euro Commercial Paper Program were at an average floating rate of 2.29% and (0.12)%, respectively. The Company does not expect changes in interest rates to have a material effect on income or cash flows in 2019, although there can be no assurances that interest rates will not change significantly.

## Controls and procedures

As filed, 2,376 characters.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures, pursuant to Rules 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. These controls and procedures are designed to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.

#### Changes in Internal Control Over Financial Reporting

Beginning January 1, 2019, the Company adopted ASU 2016-02, *Leases (Topic 842) (“*Topic 842”) and its related subsequent amendments. Although the adoption of Topic 842 did not have a material impact on our Condensed

Consolidated Statements of Income for the three and nine months ended September 30, 2019, or our Condensed Consolidated Statements of Cash Flow for the nine months ended September 30, 2019, the Company implemented changes to our processes related to our lease commitments and the related control activities, including the implementation of a new lease management system and certain controls over financial reporting necessary for the required disclosures, as well as the implementation of new policies and any necessary changes to existing related policies. Refer to Notes 2 and 15 of the accompanying Condensed Consolidated Financial Statements for further discussion on the adoption of Topic 842. There has been no other change in our internal control over financial reporting during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 134 characters.

There have been no material changes to the Company’s risk factors as disclosed in Part I, Item 1A of the Company’s 2018 Annual Report.

Filed Oct 25, 2019.
Source: SEC EDGAR, the filing index for accession 0001558370-19-009160. Last ingested by Listed: Nov 3, 2026, 18:42 ET. No prices; not investment advice.
